Erica Sutter | White & Case LLP International Law Firm, Global Law Practice

Erica Sutter

Associate, Silicon Valley

Overview

Erica Sutter is a litigation associate in the firm's Global Competition and Antitrust practice group, an award-winning practice that has been named Competition Group of the Year six years in a row by Law360. She concentrates on complex commercial antitrust litigation matters including merger litigation, class action price fixing litigation, and antitrust challenges arising out of settlement agreements from prior pharmaceutical patent cases. 

In addition to her work in antitrust litigation, Erica’s background in molecular biology is a valuable asset she uses in practicing complex intellectual property litigation, particularly in pharmaceutical patent infringement actions arising under the Hatch-Waxman Act.

Prior to joining White & Case, Erica worked with bio fabrication start-up, Modern Meadow, where she worked with outside counsel on Modern Meadow's patent and trademark applications. She was also a member of teams conducting stem cell research, including induced pluripotent stem cells, at North Carolina State University College of Veterinary Medicine and at the University College London.

Bars and Courts

  • California State Bar
  • US Court of Appeals for the Ninth Circuit
  • US District Courts for the Central, Eastern, Northern and Southern Districts of California
  • District of Columbia Bar

Education

  • BS, Biological Sciences – Molecular, Cellular, and Developmental, North Carolina State University
  • BA, International Studies, North Carolina State University
  • JD, Santa Clara University School of Law

Languages

  • English

Experience

Represented Anthem, Inc., in its defense against the US Department of Justice's lawsuit to block Anthem’s $54.2 billion agreement to acquire Cigna Corporation, the largest merger ever in the health insurance industry.  Erica was a member of the trial team defending Anthem in District Court and also a member of the team representing Anthem on its expedited appeal to the D.C. Circuit and subsequent petition for a writ of certiorari to the US Supreme Court.